At the interview by NIKKEI Biotech, CEO Hideaki Ogasawara talks about Tanso Biosciences' proprietary GPCR functional assay, which surpasses existing methods in sensitivity, comprehensiveness, and cost-effectiveness.
[blogcard url="https://bio.nikkeibp.co.jp/atcl/column/16/021500017/031200159/"]
